PMID: 25742784Mar 7, 2015Paper

A new chemical inhibitor of angiogenesis and tumorigenesis that targets the VEGF signaling pathway upstream of Ras

Oncotarget
Agnès Desroches-CastanJean-Jacques Feige

Abstract

The efficacy of anti-angiogenic therapies on cancer patients is limited by the emergence of drug resistance, urging the search for second-generation drugs. In this study, we screened an academic chemical library (DCM, University of Grenoble-Alpes) and identified a leader molecule, COB223, that inhibits endothelial cell migration and proliferation. It inhibits also Lewis lung carcinoma (LLC/2) cell proliferation whereas it does not affect fibroblast proliferation. The anti-angiogenic activity of COB223 was confirmed using several in vitro and in vivo assays. In a mouse LLC/2 tumor model, ip administration of doses as low as 4 mg/kg COB223 efficiently reduced the tumor growth rate. We observed that COB223 inhibits endothelial cell ERK1/2 phosphorylation induced by VEGF, FGF-2 or serum and that it acts downstream of PKC and upstream of Ras. This molecule represents a novel anti-angiogenic and anti-tumorigenic agent with an original mechanism of action that deserves further development as an anti-cancer drug.

References

Dec 1, 1992·The Journal of Investigative Dermatology·E W AdesT J Lawley
Jan 1, 1991·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·R S Kerbel
Jun 28, 1996·The Journal of Biological Chemistry·P LenormandJ Pouysségur
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·D VittetP Huber
Jan 15, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·M WellnerH Haller
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
Jul 6, 2000·Bioorganic & Medicinal Chemistry·L W DeadyW A Denny
Apr 17, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·B VailhéJ J Feige
Jun 5, 2003·Nature Reviews. Cancer·Gabriele Bergers, Laura E Benjamin
Jun 5, 2003·Expert Opinion on Investigational Drugs·Francesco CaponigroJane Bryce
Sep 25, 2003·Bioorganic & Medicinal Chemistry Letters·Ahmed KamalP Praveen Kumar
Jan 30, 2004·Cancer Cell·Mikhail V Blagosklonny
May 12, 2004·Nature Reviews. Drug Discovery·Napoleone FerraraWilliam Novotny
Sep 1, 2004·Cellular Signalling·Shigeru KandaHiroshi Kanetake
Dec 16, 2005·Nature·Napoleone Ferrara, Robert S Kerbel
Oct 20, 2009·Trends in Pharmacological Sciences·Yongping Crawford, Napoleone Ferrara
Mar 9, 2011·Biochemical Pharmacology·Esther M Bridges, Adrian L Harris
Apr 12, 2011·Journal of Surgical Oncology·David Berz, Harold Wanebo
Jun 28, 2011·Nature Reviews. Drug Discovery·David C Swinney, Jason Anthony
Jun 13, 2012·The Journal of Experimental Medicine·Zuyue SunLena Claesson-Welsh
Aug 10, 2012·Physiology·Michael Simons
Oct 12, 2012·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Michelle KeramidasJean-Luc Coll

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.